BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27809646)

  • 1. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
    Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
    Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
    Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
    Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
    Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
    Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
    Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine.
    Ajdari SE; Shafiei B; Motazedian M; Qutbi M; Esmaeilzadeh P; Asli IN; Javadi H; Assadi M
    Nuklearmedizin; 2019 Jun; 58(3):249-257. PubMed ID: 31060081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of dynamic risk stratification in pediatric differentiated thyroid cancer.
    Sohn SY; Kim YN; Kim HI; Kim TH; Kim SW; Chung JH
    Endocrine; 2017 Oct; 58(1):167-175. PubMed ID: 28822062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
    Majeed AK; Satapathy S; Ballal S; Bal C
    J Clin Endocrinol Metab; 2023 May; 108(6):e208-e215. PubMed ID: 36577747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
    Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
    J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation.
    Hong CM; Lee WK; Jeong SY; Lee SW; Ahn BC; Lee J
    Nucl Med Commun; 2014 Nov; 35(11):1119-26. PubMed ID: 25144561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of presentation and clinical outcome between children and young adults with differentiated thyroid cancer.
    Wang JT; Huang R; Kuang AR
    Asian Pac J Cancer Prev; 2014; 15(17):7271-5. PubMed ID: 25227827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: A Referral Center Experience.
    Scheffel RS; Zanella AB; Antunes D; Dora JM; Maia AL
    Thyroid; 2015 Aug; 25(8):883-9. PubMed ID: 26061907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
    Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.
    Vaisman F; Momesso D; Bulzico DA; Pessoa CH; Dias F; Corbo R; Vaisman M; Tuttle RM
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):132-8. PubMed ID: 22248037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.
    Kim TH; Ki CS; Kim HS; Kim K; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim SW; Chung JH
    J Clin Endocrinol Metab; 2017 May; 102(5):1757-1764. PubMed ID: 28323925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck Ultrasound in Patients with Follicular Thyroid Carcinoma.
    Segkos K; Porter K; Senter L; Ringel MD; Nabhan FA
    Horm Cancer; 2018 Dec; 9(6):433-439. PubMed ID: 30088223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.